Endocare Technique Receives FDA Approval

Endocare Inc., an Irvine developer of cold treatments for prostate cancer, said Wednesday that it has received clearance from the Food and Drug Administration to market an improved method of performing cryosurgery.

The medical device company said in a press release that its “percutaneous access introducer” is designed to establish direct access into the prostate for faster and easier placement of the cryoprobe, which kills targeted tumors by freezing them.